---
title: "CSC Financial Keeps Their Buy Rating on JD Health International, Inc. (6618)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286529854.md"
description: "In a report released yesterday, from CSC Financial maintained a Buy rating on JD Health International, Inc., with a price target of HK$58.28.Claim 55% Off TipRanksUnlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks The word on The Street in general, suggests a Strong Buy analyst consensus rating for JD Health International, Inc. with a HK$73.11 average price target."
datetime: "2026-05-15T07:56:20.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286529854.md)
  - [en](https://longbridge.com/en/news/286529854.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286529854.md)
---

# CSC Financial Keeps Their Buy Rating on JD Health International, Inc. (6618)

In a report released yesterday, from CSC Financial maintained a Buy rating on JD Health International, Inc., with a price target of HK$58.28.

### Claim 55% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

The word on The Street in general, suggests a Strong Buy analyst consensus rating for JD Health International, Inc. with a HK$73.11 average price target.

### Related Stocks

- [06618.HK](https://longbridge.com/en/quote/06618.HK.md)
- [601066.CN](https://longbridge.com/en/quote/601066.CN.md)
- [06066.HK](https://longbridge.com/en/quote/06066.HK.md)
- [86618.HK](https://longbridge.com/en/quote/86618.HK.md)

## Related News & Research

- [JD Health files HKEX next-day disclosure, reports share repurchase at HKD 41.92](https://longbridge.com/en/news/286926137.md)
- [DBS Reaffirms Their Buy Rating on JD (JD)](https://longbridge.com/en/news/286526290.md)
- [Huatai Securities Remains a Buy on JD Health International, Inc. (6618)](https://longbridge.com/en/news/271739197.md)
- [JD.com Announces First Quarter 2026 Results | JD Stock News](https://longbridge.com/en/news/286072462.md)
- [JD.com Starts 2026 with Revenue Growth and Stronger Retail Margins Despite Profit Decline](https://longbridge.com/en/news/286078055.md)